Glutathione Deficiency During Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague-Dawley Rats

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Jul 2

PMID 34201038

Citations 11

Authors

Marta Anna Lech

Monika Leskiewicz

Kinga Kaminska

Zofia Rogoz

Elzbieta Lorenc-Koci

Affiliations

Soon will be listed here.

Abstract

Growing body of evidence points to dysregulation of redox status in the brain as an important factor in the pathogenesis of schizophrenia. The aim of our study was to evaluate the effects of l-buthionine-(,)-sulfoximine (BSO), a glutathione (GSH) synthesis inhibitor, and 1-[2-Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride (GBR 12909), a dopamine reuptake inhibitor, given alone or in combination, to Sprague-Dawley pups during early postnatal development (p5-p16), on the time course of the onset of schizophrenia-like behaviors, and on the expression of brain-derived neurotrophic factor (BDNF) mRNA and its protein in the prefrontal cortex (PFC) and hippocampus (HIP) during adulthood. BSO administered alone decreased the levels of BDNF mRNA and its protein both in the PFC and HIP. Treatment with the combination of BSO + GBR 12909 also decreased BDNF mRNA and its protein in the PFC, but in the HIP, only the level of BDNF protein was decreased. Schizophrenia-like behaviors in rats were assessed at three time points of adolescence (p30, p42-p44, p60-p62) and in early adulthood (p90-p92) using the social interaction test, novel object recognition test, and open field test. Social and cognitive deficits first appeared in the middle adolescence stage and continued to occur into adulthood, both in rats treated with BSO alone or with the BSO + GBR 12909 combination. Behavior corresponding to positive symptoms in humans occurred in the middle adolescence period, only in rats treated with BSO + GBR 12909. Only in the latter group, amphetamine exacerbated the existing positive symptoms in adulthood. Our data show that rats receiving the BSO + GBR 12909 combination in the early postnatal life reproduced virtually all symptoms observed in patients with schizophrenia and, therefore, can be considered a valuable neurodevelopmental model of this disease.

Citing Articles

Behavioral Test Scores Could Be Linked to the Protein Expression Values of p62 and GLAST in the Brains of Mice with Neuropsychiatric Disorder-Related Behaviors.

Ikeda Y, Nakashima M, Yoshikawa S, Taniguchi K, Suga N, Matsuda S Biology (Basel). 2025; 13(12.

PMID: 39765706 PMC: 11672909. DOI: 10.3390/biology13121039.

Iron administered in the neonatal period changed memory, brain monoamine levels, and BDNF mRNA expression in adult Sprague-Dawley rats.

Rogoz Z, Kaminska K, Lorenc-Koci E, Wasik A Pharmacol Rep. 2024; 76(5):1044-1054.

PMID: 39012420 PMC: 11387440. DOI: 10.1007/s43440-024-00626-0.

The effect of phencyclidine-mediated blockade of NMDA receptors in the early postnatal period on glutathione and sulfur amino acid levels in the rat brain as a potential causative factor of schizophrenia-like behavior in adulthood.

Lorenc-Koci E, Gorny M, Chwatko G, Kaminska K, Iciek M, Rogoz Z Pharmacol Rep. 2024; 76(4):863-877.

PMID: 38904712 PMC: 11294273. DOI: 10.1007/s43440-024-00607-3.

Disturbances of the Lung Glutathione System in Adult Guinea Pigs Following Neonatal Vitamin C or Cysteine Deficiency.

Teixeira V, Mohamed I, Lavoie J Antioxidants (Basel). 2023; 12(7).

PMID: 37507901 PMC: 10376486. DOI: 10.3390/antiox12071361.

Association of serum brain-derived neurotrophic factor level and early response to antipsychotic drug in first-episode patients with schizophrenia.

Zhao T, Tang S, Gao X, Li J, Hao R, Chen H Int J Methods Psychiatr Res. 2023; :e1982.

PMID: 37485797 PMC: 10804348. DOI: 10.1002/mpr.1982.

References

Abi-Dargham A . Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol. 2004; 7 Suppl 1:S1-5. DOI: 10.1017/S1461145704004110. View

Ben-Ari Y . Developing networks play a similar melody. Trends Neurosci. 2001; 24(6):353-60. DOI: 10.1016/s0166-2236(00)01813-0. View

Nanda D, Tolputt J, Collard K . Changes in brain glutathione levels during postnatal development in the rat. Brain Res Dev Brain Res. 1996; 94(2):238-41. DOI: 10.1016/0165-3806(96)00061-2. View

Ovenden E, McGregor N, Emsley R, Warnich L . DNA methylation and antipsychotic treatment mechanisms in schizophrenia: Progress and future directions. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 81:38-49. DOI: 10.1016/j.pnpbp.2017.10.004. View

Lipska B, Weinberger D . To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology. 2000; 23(3):223-39. DOI: 10.1016/S0893-133X(00)00137-8. View

Lepage M, Bodnar M, Bowie C . Neurocognition: clinical and functional outcomes in schizophrenia. Can J Psychiatry. 2014; 59(1):5-12. PMC: 4079224. DOI: 10.1177/070674371405900103. View

Altuntas I, Aksoy H, Coskun I, Caykoylu A, Akcay F . Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin Chem Lab Med. 2001; 38(12):1277-81. DOI: 10.1515/CCLM.2000.201. View

Do K, Trabesinger A, Lauer C, Dydak U, Hell D, Holsboer F . Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci. 2000; 12(10):3721-8. DOI: 10.1046/j.1460-9568.2000.00229.x. View

van Os J, Rutten B, Poulton R . Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull. 2008; 34(6):1066-82. PMC: 2632485. DOI: 10.1093/schbul/sbn117. View

10.

BROQUIST H . Buthionine sulfoximine, an experimental tool to induce glutathione deficiency: elucidation of glutathione and ascorbate in their role as antioxidants. Nutr Rev. 1992; 50(4 ( Pt 1)):110-1. DOI: 10.1111/j.1753-4887.1992.tb01298.x. View

11.

Tyzio R, Holmes G, Ben-Ari Y, Khazipov R . Timing of the developmental switch in GABA(A) mediated signaling from excitation to inhibition in CA3 rat hippocampus using gramicidin perforated patch and extracellular recordings. Epilepsia. 2007; 48 Suppl 5:96-105. DOI: 10.1111/j.1528-1167.2007.01295.x. View

12.

Do K, Cabungcal J, Frank A, Steullet P, Cuenod M . Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol. 2009; 19(2):220-30. DOI: 10.1016/j.conb.2009.05.001. View

13.

Ben-Ari Y, Gaiarsa J, Tyzio R, Khazipov R . GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev. 2007; 87(4):1215-84. DOI: 10.1152/physrev.00017.2006. View

14.

Tamminga C, Holcomb H . Phenotype of schizophrenia: a review and formulation. Mol Psychiatry. 2004; 10(1):27-39. DOI: 10.1038/sj.mp.4001563. View

15.

McGrath J, Saha S, Chant D, Welham J . Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008; 30:67-76. DOI: 10.1093/epirev/mxn001. View

16.

Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa J . GABAA, NMDA and AMPA receptors: a developmentally regulated 'ménage à trois'. Trends Neurosci. 1997; 20(11):523-9. DOI: 10.1016/s0166-2236(97)01147-8. View

17.

Breier A, Su T, Saunders R, Carson R, Kolachana B, de Bartolomeis A . Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A. 1997; 94(6):2569-74. PMC: 20129. DOI: 10.1073/pnas.94.6.2569. View

18.

Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P . Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci U S A. 2007; 104(42):16621-6. PMC: 2034265. DOI: 10.1073/pnas.0706778104. View

19.

Almaguer-Melian W, Cruz-Aguado R, Bergado J . Synaptic plasticity is impaired in rats with a low glutathione content. Synapse. 2000; 38(4):369-74. DOI: 10.1002/1098-2396(20001215)38:4<369::AID-SYN1>3.0.CO;2-Q. View

20.

Cruz-Aguado R, Almaguer-Melian W, Diaz C, Lorigados L, Bergado J . Behavioral and biochemical effects of glutathione depletion in the rat brain. Brain Res Bull. 2001; 55(3):327-33. DOI: 10.1016/s0361-9230(01)00484-1. View